Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | 0,56 | 2,25 | Substituce v promotoru CYP21 genu ovlivňující fenotyp nemoci u pacientů s deficitem 21-hydroxylázy
|
1,34 | 6,72 | Correlation between SMN2 copy-number, variations in expression of SMN2 mRNA and clinical outcome in SMA patients treated with phenylbutyrate and valproic acid
|
0,00 | 0,00 | Experiences with mutation analysis of epidermolysis bullosa in the Czech republic
|
0,00 | 0,00 | Mutation Analysis of Epidermolysis Bullosa in the Czech Republic
|
0,00 | 0,00 | Mutation Analysis of Dystrophic Epidermolysis Bullosa in the Czech Republic
|
0,00 | 0,00 | Analysis of molecular pathologic findings in Czech LGMD2A patients
|
Back
(c) Michal Bulant, 2011